Divergent Pathways of Mango Fractions in Promoting Metabolic Health: From Gut Microbiota Remodeling to Direct Systemic Regulation

Why It Matters

It demonstrates how mango by‑products can be transformed into functional ingredients that improve metabolic health, offering waste‑reduction and new market opportunities.

Key Takeaways

• Pulp and peel reshape gut microbiota composition.
• Peel enriches Staphylococcus; pulp enriches Bilophila.
• Kernel saponins directly modulate host steroid pathways.
• All fractions attenuate mouse weight gain, kernel strongest.
• Microbiota‑independent action suggests therapeutic potential.

Pulse Analysis

The tropical mango industry processes millions of tons annually, yet up to 60 % of each fruit ends up as peel or kernel waste. Converting this by‑product into health‑promoting ingredients aligns with circular‑economy goals and the growing demand for functional foods. The Frontiers in Nutrition study provides the first side‑by‑side comparison of mango pulp, peel, and kernel using a mouse model and integrated 16S rRNA sequencing with fecal metabolomics. By keeping dosage, duration, and analytical pipelines identical, the authors isolate the intrinsic biological actions of each fraction.

Both pulp (MPP) and peel (MPL) acted primarily through gut‑microbiota remodeling. MPP selectively enriched the bile‑acid‑associated genus Bilophila, while MPL promoted low‑abundance taxa such as Staphylococcus and Psychrobacter. These shifts coincided with up‑regulation of carbohydrate‑active enzymes and widespread changes in fecal lipid and peptide metabolites, indicating enhanced polysaccharide fermentation and altered host lipid handling. The microbial‑driven pathway translated into modest reductions in weight gain, supporting the concept that dietary fiber‑rich fruit fractions can modulate host energy balance via microbial metabolites.

In contrast, mango kernel extract (MKE) produced the strongest attenuation of weight gain despite minimal impact on the fecal metabolome. Targeted analysis linked this effect to absorbed saponins that suppressed host steroid hormone biosynthesis, a pathway largely independent of colonic microbes. Such a microbiota‑independent mechanism positions MKE as a candidate for nutraceuticals aimed at lipid and endocrine disorders. Future work should verify these findings in germ‑free models, quantify bioactive saponin doses, and conduct human trials to assess translational potential and safety. Integrating these fractions into functional food formulations could simultaneously address waste reduction and consumer demand for health‑enhancing ingredients.